Company Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-12-09 EST			5-day change	1st Jan Change
770.00 ^DKK	+0.06%		+5.91%	+106.32%

09:31am	Swedbank Robur Småbolagsfond Norden decreased 2.03 percent in November - added Netcompany to the portfolio	FW
11-21	Zealand Pharma A/S Presents at Jefferies London Healthcare Conference 2024, Nov-21-2024 09:30 AM

Business description: Zealand Pharma A/S

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity.

At the end of 2023, the Group had a portfolio of 7 products in clinical development (including 3 in phase III, 3 in phase II and 1 in phase I), and 3 products in preclinical development.

Number of employees: 298

Sales by Activity: Zealand Pharma A/S

Fiscal Period: December	2019	2020	2021	2022	2023
Biotechnology	41.33M	353M	293M	104M	343M

See all business segments

Geographical breakdown of sales: Zealand Pharma A/S

Fiscal Period: December	2019	2020	2021	2022	2023
Germany	-	149M	53M	-	295M
Denmark	-	-	-	35M	44.18M
United States	-	204M	240M	69M	4.09M
Foreign	41.33M	-	-	-	-

See all geographic segments

Managers: Zealand Pharma A/S

Director	Title	Age	Since
Adam Sinding Steensberg CEO	Chief Executive Officer	50	2022-03-29
Henriette Wennicke DFI	Director of Finance/CFO	-	2022-10-31
David M. Kendall CTO	Chief Tech/Sci/R&D Officer	62	2022-06-01
Ivan M. Møller COO	Chief Operating Officer	52	2018-02-28
Frederik Barfoed Beck PRN	Corporate Officer/Principal	57	-

See ZEALAND PHARMA A/S governance

Members of the board: Zealand Pharma A/S

Manager	Title	Age	Since
Alf Gunnar Martin Nicklasson CHM	Chairman	69	-
Kirsten Drejer BRD	Director/Board Member	68	2018-04-18
Bernadette Connaughton BRD	Director/Board Member	65	2019-04-03
Jeffrey Berkowitz BRD	Director/Board Member	58	2019-04-03
Leonard Kruimer BRD	Director/Board Member	66	2019-04-03
Frederik Barfoed Beck BRD	Director/Board Member	57	2019-12-31
Anneline Nansen BRD	Director/Board Member	55	2021-08-31
Enrique Conterno BRD	Director/Board Member	57	2024-03-19
Elaine Sullivan BRD	Director/Board Member	63	2024-03-19
Ludovic Tranholm Otterbein BRD	Director/Board Member	51	2024-03-19

Composition of the Board of Directors

Shareholders: Zealand Pharma A/S

Name	Equities	%	Valuation
Van Herk Investments BV 9.680 %	6,874,960	9.680 %	711 M kr
Polar Capital LLP 7.952 %	5,647,561	7.952 %	584 M kr
J.O. Hambro Capital Management Ltd. 4.404 %	3,128,162	4.404 %	323 M kr
Nykredit Bank A/S (Investment Management) 0.8269 %	587,304	0.8269 %	61 M kr
ZEALAND PHARMA A/S 0.5254 %	373,134	0.5254 %	39 M kr

List of ZEALAND PHARMA A/S shareholders

Holdings: Zealand Pharma A/S

Name	Equities	%	Valuation
ZEALAND PHARMA A/S 0.53%	373,134	0.53%	38,576,380 $

Company details: Zealand Pharma A/S

Zealand Pharma A/S

Sydmarken 11

2860, Soborg

+45 88 77 36 00

http://www.zealandpharma.com

Bio Therapeutic Drugs

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ZEALAND PHARMA A/S	+0.06%	+5.91%	+126.07%	+462.04%	7.71B
VERTEX PHARMACEUTICALS INCORPORATED	+2.69%	+1.81%	+33.08%	+127.51%	119B
REGENERON PHARMACEUTICALS, INC.	+1.31%	+3.30%	-7.18%	+18.29%	83.7B
ARGENX SE	-0.95%	-0.78%	+40.03%	+116.18%	37.69B
BIONTECH SE	-0.39%	+3.40%	+20.59%	-57.36%	29.18B
BEIGENE, LTD.	+0.92%	+0.85%	+18.88%	-32.10%	21.85B
WUXI APPTEC CO., LTD.	+6.81%	+17.63%	-22.39%	-57.72%	21.71B
GENMAB A/S	+0.81%	+0.64%	-29.34%	-40.87%	14.53B
SUMMIT THERAPEUTICS INC.	+1.00%	+1.19%	+790.95%	+281.84%	13.67B
INSMED INCORPORATED	-3.65%	+0.48%	+166.95%	+170.32%	13.49B
Average	+0.81%	+2.20%	+113.76%	+98.81%	36.25B
Weighted average by Cap.	+1.43%	+1.44%	+52.36%	+73.30%